|
|
Low-dose
AAV-CRISPR-mediated liver-specific knock-in restored hemostasis in
neonatal hemophilia B mice with subtle antibody response
He X*, Zhang Z*, Xue J,
Wang Y, Zhang S, Wei J, Zhang C, Wang J, Urip BA, Ngan CC, Sun J, Li Y,
Lu Z, Zhao H, Pei D, Li CK, Feng B.
Nat Commun 13, 7275 (2022)
Kidney
tubular transcription co-activator, Yes-associated protein 1 (YAP), controls
the expression of collecting duct aquaporins and water homeostasis
Zhang Y, Huang H, Kong Y,
Xu C, Dai L, Geng X, Deng Y, Wang Y, Liu Y, Meng C, Zhang X, Li J, Qin J,
Feng B, Mak KK, Wang L, Huang Y, Wang W, Lan HY, Yang B, Lu HAJ,
Xia Y.
Kidney Int 22, S0085-2538 (2022)
R4
RGS proteins suppress engraftment of human hematopoietic stem/progenitor
cells by modulating SDF-1/CXCR4 signaling
Chan KYY, Zhang C, Wong
YTS, Zhang XB, Wang CC, Ng WH, Fok SP, Tang PMK, Kang W, Feng B,
Poon ENY, Lee KY, Lee CK, Chen C, Leung TY, Ng MHL, To KF, Wang H, Lam
HS, Ng PC, Yuen PMP, Li K, Leung AWK, Li CK, Leung KT.
Blood Adv 5, 4380-4392 (2021)
Review:
Evolving AAV-delivered therapeutics towards ultimate cures
He X, Urip BA, Zhang Z,
Ngan CC, Feng B.
J Mol Med (Berl) 99, 593-617 (2021)
Establishment
of a novel CYP3A4-transduced human hepatic sinusoidal endothelial cell
model and its application in screening hepatotoxicity of pyrrolizidine
alkaloids
Lu Y, Wong KY, Tan C, Ma
J#, Feng B#, Lin G#.
J Environ Sci Health C Toxicol Carcinog 38, 169-185
(2020)
Review:
The rapidly advancing Class 2 CRISPR-Cas technologies: A customizable
toolbox for molecular manipulations
Wang J, Zhang C, Feng B.
J Cell Mol Med 24, 3256-3270 (2020)
Aberrant
enhancer hypomethylation contributes to hepatic carcinogenesis through
global transcriptional reprogramming
Xiong L, Wu F, Wu Q, Xu
L, Cheung OK, Kang W, Mok MT, Szeto LLM, Lun CY, Lung RW, Zhang J, Yu KH,
Lee SD, Huang G, Wang CM, Liu J, Yu Z, Yu DY, Chou JL, Huang WH, Feng
B, Cheung YS, Lai PB, Tan P, Wong N, Chan MW, Huang TH, Yip KY, Cheng
AS, To KF.
Nat Commun 10, 335 (2019)
Homology-independent
multiallelic disruption via CRISPR/Cas9-based knock-in yields distinct
functional outcomes in human cells
Zhang C*, He X*, Kwok YK,
Wang F, Xue J, Zhao H, Suen KW, Wang CC, Ren J, Chen GG, Lai PBS, Li J,
Xia Y, Chan AM, Chan WY#, Feng
B#.
BMC
Biology 16, 151 (2018)
Review:
New turns for high efficiency knock-in of large DNA in human
pluripotent stem cells
He X, Li YX, Feng B.
Stem Cells Int 3, 9465028 (2018)
Review: In vivo genome
editing thrives with diversified CRISPR technologies
Ma X, Wong ASY, Tam HY,
Tsui SYK, Chung DLS, Feng
B.
Zool Res 39, 58-71 (2018)
Conversion
of human gastric epithelial cells to multipotent endodermal progenitors
using defined small molecules
Wang Y, Qin J, Wang S,
Zhang W, Duan J, Zhang J, Wang X, Yan F, Chang M, Liu X, Feng B, Liu
J, Pei X.
Cell Stem Cell 19, 449-461 (2016)
Knock-in
of large reporter genes in human cells via CRISPR/Cas9-induced
homology-dependent and independent DNA repair
He X, Tan C, Wang F, Wang
Y, Zhou R, Cui D, You W, Zhao H, Ren J, Feng B.
Nucleic
Acids Res 44, e85 (2016)
Review:
Genome-wide massive sequencing in embryonic stem cell biology: Recent
insights and challenges
Wang Y, Cheung AC, Guo JT, Feng
B.
J
Stem Cell Res Ther 5, 296 (2015)
Review:
Progress and challenges in generating functional hematopoietic
stem/progenitor cells from human pluripotent stem cells
Liu S, Xu Y, Zhou Z, Feng B#, Huang
H#.
Cytotherapy 17, 344-58
(2015)
Direct
activation of human and mouse Oct4 genes using engineered TALE and Cas9
transcription factors
Hu J, Lei Y, Wong WK, Liu
S, Lee KC, He X, You W, Zhou R, Guo JT, Chen X, Peng X, Sun H, Huang H,
Zhao H, Feng B.
Nucleic
Acids Res 42, 4375-90 (2014)
Zfp322a
regulates mouse ES cell pluripotency and enhances reprogramming
efficiency
Ma H, Ng HM, Teh X, Li H,
Lee YH, Chong YM, Loh YH, Collins JJ, Feng B, Yang H#, Wu Q#.
PLoS
Genet 10, e1004038 (2014)
LIF-dependent
primitive neural stem cells derived from mouse ES cells represent a
reversible stage of neural commitment
Tsang WH*, Wang B*, Wong
WK*, Shi S*, Chen X, He X, Gu S, Hu J, Wang C, Liu PC, Lu G, Chen X, Zhao
H, Poon WS, Chan WY#, Feng
B#.
Stem
Cell Res 11, 1091-102 (2013)
SON
connects the splicing-regulatory network with pluripotency in human
embryonic stem cells
Lu X*, Goke J*, Sachs F,
Jacques PE, Liang H, Feng
B, Bourque G, Bubulya PA, Ng HH.
Nat
Cell Biol 15, 1141-1152 (2013)
A
genetic and developmental pathway from STAT3 to the OCT4-NANOG circuit is
essential for maintenance of ICM lineages in vivo
Do DV, Ueda J,
Messerschmidt DM, Lorthongpanich C, Zhou Y, Feng B, Guo G,
Lin PJ, Hossain MZ, Zhang W, Moh A, Wu Q, Robson P, Ng HH, Poellinger L,
Knowles BB, Solter D#, Fu XY#.
Genes Dev 27, 1378-90 (2013)
Efficient
commitment to functional CD34+ progenitor cells from human bone marrow
mesenchymal stem-cell-derived induced pluripotent stem cells
Xu Y, Liu L, Zhang L, Fu
S, Hu Y, Wang Y, Fu H, Wu K, Xiao H, Liu S, Yu X, Zheng W, Feng B,
Huang H.
PLoS One 7, e34321 (2012)
A
genome-wide RNAi screen reveals determinants of human embryonic stem cell
identity
Chia NY*, Chan YS*, Feng B*, Lu X,
Orlov YL, Moreau D, Kumar P, Yang L, Jiang J, Lau MS, Huss M, Soh BS,
Kraus P, Li P, Lufkin T, Lim B, Clarke ND, Bard F#, Ng HH#.
Nature 468, 316-20 (2010)
The
nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine
somatic cells to pluripotent cells
Heng JCD, Feng B, Han J,
Jiang J, Kraus P, Ng JH, Orlov YL, Huss M, Yang L, Lufkin T, Lim B, Ng
HH.
Cell
Stem Cell 6, 167-74 (2010)
Review:
Molecules that promote or enhance reprogramming of somatic cells to
induced pluripotent stem cells
Feng B,
Ng JH, Heng JCD, Ng HH#.
Cell
Stem Cell 4, 301-12 (2009)
Reprogramming
of fibroblasts into induced pluripotent stem cells with orphan nuclear
receptor Esrrb
Feng B,
Jiang J, Kraus P, Ng JH, Heng JCD, Chan YS, Yaw LP, Zhang W, Loh YH, Han
J, Vega VB, Cacheux-Rataboul V, Lim B, Lufkin T, Ng HH.
Nat
Cell Biol 11, 197-203 (2009)
* Co-first
authors
# Co-Correspondence
author
|
|
